129 related articles for article (PubMed ID: 24516561)
1. A gene expression and pre-mRNA splicing signature that marks the adenoma-adenocarcinoma progression in colorectal cancer.
Pesson M; Volant A; Uguen A; Trillet K; De La Grange P; Aubry M; Daoulas M; Robaszkiewicz M; Le Gac G; Morel A; Simon B; Corcos L
PLoS One; 2014; 9(2):e87761. PubMed ID: 24516561
[TBL] [Abstract][Full Text] [Related]
2. ETV4 plays a role on the primary events during the adenoma-adenocarcinoma progression in colorectal cancer.
Fonseca AS; Ramão A; Bürger MC; de Souza JES; Zanette DL; de Molfetta GA; de Araújo LF; de Barros E Lima Bueno R; Aguiar GM; Plaça JR; Alves CP; Dos Santos ARD; Vidal DO; Silva GEB; Panepucci RA; Peria FM; Feres O; da Rocha JJR; Zago MA; Silva WA
BMC Cancer; 2021 Mar; 21(1):207. PubMed ID: 33648461
[TBL] [Abstract][Full Text] [Related]
3. Altered expression of renin-angiotensin system receptors throughout colorectal adenoma-adenocarcinoma sequence.
Beitia M; Solano-Iturri JD; Errarte P; Sanz B; Perez I; Etxezarraga MC; Loizate A; Asumendi A; Larrinaga G
Int J Med Sci; 2019; 16(6):813-821. PubMed ID: 31337954
[No Abstract] [Full Text] [Related]
4. Distinct changes of dendritic cell number and IL-12 mRNA level in adjacent mucosa throughout the colorectal adenoma-carcinoma sequence.
Cui G; Yuan A; Goll R; Olsen T; Husebekk A; Vonen B; Florholmen J
Cancer Immunol Immunother; 2007 Dec; 56(12):1993-2001. PubMed ID: 17579859
[TBL] [Abstract][Full Text] [Related]
5. Long-read sequencing reveals the landscape of aberrant alternative splicing and novel therapeutic target in colorectal cancer.
Sun Q; Han Y; He J; Wang J; Ma X; Ning Q; Zhao Q; Jin Q; Yang L; Li S; Li Y; Zhi Q; Zheng J; Dong D
Genome Med; 2023 Sep; 15(1):76. PubMed ID: 37735421
[TBL] [Abstract][Full Text] [Related]
6. A merged microarray meta-dataset for transcriptionally profiling colorectal neoplasm formation and progression.
Rohr M; Beardsley J; Nakkina SP; Zhu X; Aljabban J; Hadley D; Altomare D
Sci Data; 2021 Aug; 8(1):214. PubMed ID: 34381057
[TBL] [Abstract][Full Text] [Related]
7. Validity of pathological diagnosis for early colorectal cancer in genetic background.
Okimoto K; Hirotsu Y; Arai M; Amemiya K; Akizue N; Ohta Y; Taida T; Saito K; Ohyama H; Matsumura T; Nishimura M; Matsushita K; Matsusaka K; Oyama T; Mochizuki H; Chiba T; Kato J; Ikeda JI; Yokosuka O; Kato N; Omata M
Cancer Med; 2023 Apr; 12(7):8490-8498. PubMed ID: 36734304
[TBL] [Abstract][Full Text] [Related]
8. Pleiotropic role of NOTUM in colorectal cancer.
van Driel MS; Linssen JDG; van Neerven SM; Vermeulen L
Gut; 2023 Nov; 72(12):2222-2223. PubMed ID: 37884353
[No Abstract] [Full Text] [Related]
9. miR-4709 overexpression facilitates cancer proliferation and invasion via downregulating NR3C2 and is an unfavorable prognosis factor in colon adenocarcinoma.
Yu M; Yu HL; Li QH; Zhang L; Chen YX
J Biochem Mol Toxicol; 2019 Dec; 33(12):e22411. PubMed ID: 31621980
[TBL] [Abstract][Full Text] [Related]
10. ITIH5, as a predictor of prognosis and immunotherapy response for P53-like bladder cancer, is related to cell proliferation and invasion.
Peng K; Ding D; Wang N; Du T; Wang L; Duan X
Mol Omics; 2023 Oct; 19(9):714-725. PubMed ID: 37431189
[TBL] [Abstract][Full Text] [Related]
11. The ECM Modulator ITIH5 Affects Cell Adhesion, Motility and Chemotherapeutic Response of Basal/Squamous-Like (BASQ) Bladder Cancer Cells.
Rose M; Noetzel E; Kistermann J; Eschenbruch J; Rushrush S; Gan L; Knüchel R; Gaisa NT; Dahl E
Cells; 2021 Apr; 10(5):. PubMed ID: 33924987
[TBL] [Abstract][Full Text] [Related]
12. Suppression of pancreatic cancer liver metastasis by secretion-deficient ITIH5.
Young ED; Manley SJ; Beadnell TC; Shearin AE; Sasaki K; Zimmerman R; Kauffman E; Vivian CJ; Parasuram A; Iwakuma T; Grandgenett PM; Hollingsworth MA; O'Neil M; Welch DR
Br J Cancer; 2021 Jan; 124(1):166-175. PubMed ID: 33024269
[TBL] [Abstract][Full Text] [Related]
13. ITIH5 induces a shift in TGF-β superfamily signaling involving Endoglin and reduces risk for breast cancer metastasis and tumor death.
Rose M; Meurer SK; Kloten V; Weiskirchen R; Denecke B; Antonopoulos W; Deckert M; Knüchel R; Dahl E
Mol Carcinog; 2018 Feb; 57(2):167-181. PubMed ID: 28940371
[TBL] [Abstract][Full Text] [Related]
14. ITIH5 mediates epigenetic reprogramming of breast cancer cells.
Rose M; Kloten V; Noetzel E; Gola L; Ehling J; Heide T; Meurer SK; Gaiko-Shcherbak A; Sechi AS; Huth S; Weiskirchen R; Klaas O; Antonopoulos W; Lin Q; Wagner W; Veeck J; Gremse F; Steitz J; Knüchel R; Dahl E
Mol Cancer; 2017 Feb; 16(1):44. PubMed ID: 28231808
[TBL] [Abstract][Full Text] [Related]
15. Decreased ITIH5 expression is associated with poor prognosis in primary gastric cancer.
Mai C; Zhao JJ; Tang XF; Wang W; Pan K; Pan QZ; Zhang XF; Jiang SS; Zhao BW; Li YF; Xia JC; Zhou ZW
Med Oncol; 2014 Jul; 31(7):53. PubMed ID: 24913813
[TBL] [Abstract][Full Text] [Related]
16. An Overview on the Emerging Role of the Plasma Protease Inhibitor Protein ITIH5 as a Metastasis Suppressor.
Subramaniyam K; Harihar S
Cell Biochem Biophys; 2024 Feb; ():. PubMed ID: 38355846
[TBL] [Abstract][Full Text] [Related]
17. Microsatellite Instability and Aberrant Pre-mRNA Splicing: How Intimate Is It?
Corcos L; Le Scanf E; Quéré G; Arzur D; Cueff G; Jossic-Corcos CL; Le Maréchal C
Genes (Basel); 2023 Jan; 14(2):. PubMed ID: 36833239
[TBL] [Abstract][Full Text] [Related]
18. Identification of Key MicroRNAs and Genes between Colorectal Adenoma and Colorectal Cancer via Deep Learning on GEO Databases and Bioinformatics.
Zhang X; Jin M; Liu F; Qu H; Chen C
Contrast Media Mol Imaging; 2023; 2023():6457152. PubMed ID: 36793496
[TBL] [Abstract][Full Text] [Related]
19. KCNJ14 knockdown significantly inhibited the proliferation and migration of colorectal cells.
Li B; Ge N; Pan Z; Hou C; Xie K; Wang D; Liu J; Wan J; Deng F; Li M; Luo S
BMC Med Genomics; 2022 Sep; 15(1):194. PubMed ID: 36100894
[TBL] [Abstract][Full Text] [Related]
20. The SKA3-DUSP2 Axis Promotes Gastric Cancer Tumorigenesis and Epithelial-Mesenchymal Transition by Activating the MAPK/ERK Pathway.
Zhang C; Zhao S; Tan Y; Pan S; An W; Chen Q; Wang X; Xu H
Front Pharmacol; 2022; 13():777612. PubMed ID: 35295342
[No Abstract] [Full Text] [Related]
[Next] [New Search]
